The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bone Morphogenetic Proteins Market Research Report 2024

Global Bone Morphogenetic Proteins Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1413377

No of Pages : 81

Synopsis
Bone morphogenetic proteins (BMPs) are a group of growth factors also known as cytokines and as metabologens.Originally discovered by their ability to induce the formation of bone and cartilage, BMPs are now considered to constitute a group of pivotal morphogenetic signals, orchestrating tissue architecture throughout the body.
The global Bone Morphogenetic Proteins market was valued at US$ 498.1 million in 2023 and is anticipated to reach US$ 598.6 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
North American market for Bone Morphogenetic Proteins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bone Morphogenetic Proteins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Bone Morphogenetic Proteins include Medtronic, Cellumed, Stryker, Sigma Aldrich, ProSpec, Ember therapeutics, R&D Systems and Thermo Fischer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Bone Morphogenetic Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone Morphogenetic Proteins.
Report Scope
The Bone Morphogenetic Proteins market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bone Morphogenetic Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bone Morphogenetic Proteins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Cellumed
Stryker
Sigma Aldrich
ProSpec
Ember therapeutics
R&D Systems
Thermo Fischer
Segment by Type
rhBMP-2
rhBMP-7
Segment by Application
Spinal Fusion
Trauma
Reconstructive Surgery
Oral-Maxillofacial
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bone Morphogenetic Proteins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bone Morphogenetic Proteins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Bone Morphogenetic Proteins Market Overview
1.1 Product Overview and Scope of Bone Morphogenetic Proteins
1.2 Bone Morphogenetic Proteins Segment by Type
1.2.1 Global Bone Morphogenetic Proteins Market Value Comparison by Type (2024-2030)
1.2.2 rhBMP-2
1.2.3 rhBMP-7
1.3 Bone Morphogenetic Proteins Segment by Application
1.3.1 Global Bone Morphogenetic Proteins Market Value by Application: (2024-2030)
1.3.2 Spinal Fusion
1.3.3 Trauma
1.3.4 Reconstructive Surgery
1.3.5 Oral-Maxillofacial
1.3.6 Others
1.4 Global Bone Morphogenetic Proteins Market Size Estimates and Forecasts
1.4.1 Global Bone Morphogenetic Proteins Revenue 2019-2030
1.4.2 Global Bone Morphogenetic Proteins Sales 2019-2030
1.4.3 Global Bone Morphogenetic Proteins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Bone Morphogenetic Proteins Market Competition by Manufacturers
2.1 Global Bone Morphogenetic Proteins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Bone Morphogenetic Proteins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Bone Morphogenetic Proteins Average Price by Manufacturers (2019-2024)
2.4 Global Bone Morphogenetic Proteins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Bone Morphogenetic Proteins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bone Morphogenetic Proteins, Product Type & Application
2.7 Bone Morphogenetic Proteins Market Competitive Situation and Trends
2.7.1 Bone Morphogenetic Proteins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bone Morphogenetic Proteins Players Market Share by Revenue
2.7.3 Global Bone Morphogenetic Proteins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bone Morphogenetic Proteins Retrospective Market Scenario by Region
3.1 Global Bone Morphogenetic Proteins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Bone Morphogenetic Proteins Global Bone Morphogenetic Proteins Sales by Region: 2019-2030
3.2.1 Global Bone Morphogenetic Proteins Sales by Region: 2019-2024
3.2.2 Global Bone Morphogenetic Proteins Sales by Region: 2025-2030
3.3 Global Bone Morphogenetic Proteins Global Bone Morphogenetic Proteins Revenue by Region: 2019-2030
3.3.1 Global Bone Morphogenetic Proteins Revenue by Region: 2019-2024
3.3.2 Global Bone Morphogenetic Proteins Revenue by Region: 2025-2030
3.4 North America Bone Morphogenetic Proteins Market Facts & Figures by Country
3.4.1 North America Bone Morphogenetic Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Bone Morphogenetic Proteins Sales by Country (2019-2030)
3.4.3 North America Bone Morphogenetic Proteins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Bone Morphogenetic Proteins Market Facts & Figures by Country
3.5.1 Europe Bone Morphogenetic Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Bone Morphogenetic Proteins Sales by Country (2019-2030)
3.5.3 Europe Bone Morphogenetic Proteins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bone Morphogenetic Proteins Market Facts & Figures by Country
3.6.1 Asia Pacific Bone Morphogenetic Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Bone Morphogenetic Proteins Sales by Country (2019-2030)
3.6.3 Asia Pacific Bone Morphogenetic Proteins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Bone Morphogenetic Proteins Market Facts & Figures by Country
3.7.1 Latin America Bone Morphogenetic Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Bone Morphogenetic Proteins Sales by Country (2019-2030)
3.7.3 Latin America Bone Morphogenetic Proteins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bone Morphogenetic Proteins Market Facts & Figures by Country
3.8.1 Middle East and Africa Bone Morphogenetic Proteins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Bone Morphogenetic Proteins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Bone Morphogenetic Proteins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Bone Morphogenetic Proteins Sales by Type (2019-2030)
4.1.1 Global Bone Morphogenetic Proteins Sales by Type (2019-2024)
4.1.2 Global Bone Morphogenetic Proteins Sales by Type (2025-2030)
4.1.3 Global Bone Morphogenetic Proteins Sales Market Share by Type (2019-2030)
4.2 Global Bone Morphogenetic Proteins Revenue by Type (2019-2030)
4.2.1 Global Bone Morphogenetic Proteins Revenue by Type (2019-2024)
4.2.2 Global Bone Morphogenetic Proteins Revenue by Type (2025-2030)
4.2.3 Global Bone Morphogenetic Proteins Revenue Market Share by Type (2019-2030)
4.3 Global Bone Morphogenetic Proteins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Bone Morphogenetic Proteins Sales by Application (2019-2030)
5.1.1 Global Bone Morphogenetic Proteins Sales by Application (2019-2024)
5.1.2 Global Bone Morphogenetic Proteins Sales by Application (2025-2030)
5.1.3 Global Bone Morphogenetic Proteins Sales Market Share by Application (2019-2030)
5.2 Global Bone Morphogenetic Proteins Revenue by Application (2019-2030)
5.2.1 Global Bone Morphogenetic Proteins Revenue by Application (2019-2024)
5.2.2 Global Bone Morphogenetic Proteins Revenue by Application (2025-2030)
5.2.3 Global Bone Morphogenetic Proteins Revenue Market Share by Application (2019-2030)
5.3 Global Bone Morphogenetic Proteins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic Bone Morphogenetic Proteins Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Cellumed
6.2.1 Cellumed Corporation Information
6.2.2 Cellumed Description and Business Overview
6.2.3 Cellumed Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Cellumed Bone Morphogenetic Proteins Product Portfolio
6.2.5 Cellumed Recent Developments/Updates
6.3 Stryker
6.3.1 Stryker Corporation Information
6.3.2 Stryker Description and Business Overview
6.3.3 Stryker Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Stryker Bone Morphogenetic Proteins Product Portfolio
6.3.5 Stryker Recent Developments/Updates
6.4 Sigma Aldrich
6.4.1 Sigma Aldrich Corporation Information
6.4.2 Sigma Aldrich Description and Business Overview
6.4.3 Sigma Aldrich Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sigma Aldrich Bone Morphogenetic Proteins Product Portfolio
6.4.5 Sigma Aldrich Recent Developments/Updates
6.5 ProSpec
6.5.1 ProSpec Corporation Information
6.5.2 ProSpec Description and Business Overview
6.5.3 ProSpec Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ProSpec Bone Morphogenetic Proteins Product Portfolio
6.5.5 ProSpec Recent Developments/Updates
6.6 Ember therapeutics
6.6.1 Ember therapeutics Corporation Information
6.6.2 Ember therapeutics Description and Business Overview
6.6.3 Ember therapeutics Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ember therapeutics Bone Morphogenetic Proteins Product Portfolio
6.6.5 Ember therapeutics Recent Developments/Updates
6.7 R&D Systems
6.6.1 R&D Systems Corporation Information
6.6.2 R&D Systems Description and Business Overview
6.6.3 R&D Systems Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 R&D Systems Bone Morphogenetic Proteins Product Portfolio
6.7.5 R&D Systems Recent Developments/Updates
6.8 Thermo Fischer
6.8.1 Thermo Fischer Corporation Information
6.8.2 Thermo Fischer Description and Business Overview
6.8.3 Thermo Fischer Bone Morphogenetic Proteins Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Thermo Fischer Bone Morphogenetic Proteins Product Portfolio
6.8.5 Thermo Fischer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bone Morphogenetic Proteins Industry Chain Analysis
7.2 Bone Morphogenetic Proteins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bone Morphogenetic Proteins Production Mode & Process
7.4 Bone Morphogenetic Proteins Sales and Marketing
7.4.1 Bone Morphogenetic Proteins Sales Channels
7.4.2 Bone Morphogenetic Proteins Distributors
7.5 Bone Morphogenetic Proteins Customers
8 Bone Morphogenetic Proteins Market Dynamics
8.1 Bone Morphogenetic Proteins Industry Trends
8.2 Bone Morphogenetic Proteins Market Drivers
8.3 Bone Morphogenetic Proteins Market Challenges
8.4 Bone Morphogenetic Proteins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’